As circulating LVSELs were different from those present in the BM due to the permanent exchange of the latter with the medullary microenvironment of stem cell niche, we also monitored BCR-ABL expression in stem cells isolated from the BM of CML patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.